Cambridge Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.02M | Buy |
37,892
+847
| +2% | +$64.7K | 0.11% | 104 |
|
|
2023
Q4 | $2.93M | Sell |
37,045
-17,571
| -32% | -$1.25M | 0.12% | 98 |
|
|
2023
Q3 | $3.81M | Sell |
54,616
-312,451
| -85% | -$22.1M | 0.18% | 93 |
|
|
2023
Q2 | $25.4M | Sell |
367,067
-14,710
| -4% | -$1.05M | 1.15% | 30 |
|
|
2023
Q1 | $28.4M | Buy |
381,777
+50,524
| +15% | +$4.24M | 1.35% | 24 |
|
|
2022
Q4 | $30.9M | Sell |
331,253
-8,261
| -2% | -$797K | 1.38% | 24 |
|
|
2022
Q3 | $32.4M | Buy |
339,514
+98,604
| +41% | +$9.76M | 1.54% | 16 |
|
|
2022
Q2 | $22.3M | Buy |
240,910
+100,822
| +72% | +$9.84M | 0.98% | 36 |
|
|
2022
Q1 | $14.2M | Buy |
140,088
+31,177
| +29% | +$3.28M | 0.5% | 66 |
|
|
2021
Q4 | $11.2M | Buy |
108,911
+95,460
| +710% | +$8.82M | 0.36% | 77 |
|
|
2021
Q3 | $1.14M | Buy |
13,451
+600
| +5% | +$50.3K | 0.04% | 130 |
|
|
2021
Q2 | $1.07M | Buy |
12,851
+1,715
| +15% | +$140K | 0.04% | 136 |
|
|
2021
Q1 | $837K | Buy |
11,136
+7,173
| +181% | +$522K | 0.03% | 150 |
|
|
2020
Q4 | $271K | Sell |
3,963
-758
| -16% | -$49.3K | 0.01% | 202 |
|
|
2020
Q3 | $276K | Sell |
4,721
-1,479
| -24% | -$92K | 0.01% | 196 |
|
|
2020
Q2 | $403K | Sell |
6,200
-2,118
| -25% | -$133K | 0.02% | 171 |
|
|
2020
Q1 | $493K | Buy |
8,318
+2,126
| +34% | +$142K | 0.03% | 155 |
|
|
2019
Q4 | $460K | Buy |
6,192
+296
| +5% | +$20.8K | 0.02% | 188 |
|
|
2019
Q3 | $372K | Buy |
5,896
+1,022
| +21% | +$60.6K | 0.02% | 195 |
|
|
2019
Q2 | $266K | Sell |
4,874
-720
| -13% | -$38.8K | 0.02% | 222 |
|
|
2019
Q1 | $302K | Sell |
5,594
-3,038
| -35% | -$188K | 0.02% | 210 |
|
|
2018
Q4 | $566K | Sell |
8,632
-1,001
| -10% | -$74.7K | 0.04% | 158 |
|
|
2018
Q3 | $759K | Buy |
9,633
+147
| +2% | +$10.5K | 0.04% | 148 |
|
|
2018
Q2 | $611K | Sell |
9,486
-1,439
| -13% | -$94.8K | 0.04% | 163 |
|
|
2018
Q1 | $679K | Sell |
10,925
-1,107
| -9% | -$79.4K | 0.04% | 160 |
|
|
2017
Q4 | $872K | Sell |
12,032
-1,317
| -10% | -$95.8K | 0.06% | 140 |
|
|
2017
Q3 | $1.08M | Sell |
13,349
-990
| -7% | -$78.3K | 0.07% | 123 |
|
|
2017
Q2 | $1.15M | Sell |
14,339
-7,442
| -34% | -$588K | 0.08% | 121 |
|
|
2017
Q1 | $1.71M | Sell |
21,781
-130,743
| -86% | -$10.4M | 0.11% | 108 |
|
|
2016
Q4 | $12M | Sell |
152,524
-18,557
| -11% | -$1.5M | 0.85% | 44 |
|
|
2016
Q3 | $15.2M | Sell |
171,081
-66,310
| -28% | -$6.26M | 1.11% | 34 |
|
|
2016
Q2 | $22.7M | Sell |
237,391
-1,461
| -0.6% | -$146K | 1.74% | 13 |
|
|
2016
Q1 | $24.8M | Buy |
238,852
+7,967
| +3% | +$775K | 2.03% | 9 |
|
|
2015
Q4 | $22.6M | Buy |
230,885
+1,526
| +0.7% | +$149K | 1.85% | 13 |
|
|
2015
Q3 | $22.1M | Buy |
229,359
+1,988
| +0.9% | +$209K | 1.94% | 13 |
|
|
2015
Q2 | $23.8M | Sell |
227,371
-498
| -0.2% | -$50.9K | 1.97% | 13 |
|
|
2015
Q1 | $23.5M | Buy |
227,869
+1,024
| +0.5% | +$104K | 1.98% | 11 |
|
|
2014
Q4 | $21.8M | Buy |
226,845
+337
| +0.1% | +$29.7K | 1.9% | 13 |
|
|
2014
Q3 | $18M | Buy |
226,508
+581
| +0.3% | +$45.8K | 1.6% | 20 |
|
|
2014
Q2 | $17M | Buy |
225,927
+960
| +0.4% | +$72.6K | 1.47% | 21 |
|
|
2014
Q1 | $16.8M | Sell |
224,967
-2,557
| -1% | -$181K | 1.55% | 22 |
|
|
2013
Q4 | $16.3M | Sell |
227,524
-1,920
| -0.8% | -$123K | 1.51% | 24 |
|
|
2013
Q3 | $13M | Sell |
229,444
-3,221
| -1% | -$192K | 1.3% | 31 |
|
|
2013
Q2 | $13.3M | Buy |
+232,665
| New | +$13.5M | 1.38% | 28 |
|
Other funds holding CVS
Cambridge Trust's CVS Position: Q1 2024 in Review
Cambridge Trust increased its CVS Health (CVS) stake by 2.3% in Q1 2024, buying an estimated $64.7K and bringing the position to 37,892 shares worth $3.02M. The position accounts for 0.11% of the portfolio, ranked #104.
Cambridge Trust first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $32.4M in Q3 2022. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.
- Cambridge Trust held 37,892 shares of CVS Health worth $3.02M as of Q1 2024.
- Cambridge Trust bought 847 CVS Health shares in Q1 2024, an estimated $64.7K.
- CVS Health made up 0.11% of Cambridge Trust's portfolio in Q1 2024, its #104 holding.
- Cambridge Trust first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
- Cambridge Trust's CVS Health position peaked at $32.4M in Q3 2022.
- 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.